Eurofins Viracor Establishes Lenexa, Kansas, Laboratory Complex
10/07/2022
The new 110,000-square-foot-facility is part of the company’s continued investment in building capacity and capabilities to meet growing customer demand in biopharma and clinical diagnostic testing services, according to company officials. The location will allow for expanded molecular/genomic, next generation sequencing, immunoassay, cell-based, LCMS, and other bioanalytical testing services.
"I'm proud that an innovative company like Eurofins Viracor has chosen to call Kansas home," said Governor Laura Kelly. "Beyond providing 235 more Kansans with high-quality jobs, Eurofins Viracor will continue its crucial work to keep our nation safe and healthy."
Viracor Eurofins Laboratories is a diagnostic laboratory specializing in infectious disease, immunology and allergy testing for immunocompromised and critical patients.
"Governor Kelly's Kansas Framework for Growth specifically targets recruiting additional company headquarters and enhancing our state's bioscience sector," Lieutenant Governor and Secretary of Commerce David Toland noted. "Eurofins Viracor is the type of visionary company we want to attract to Kansas."
The Eurofins Viracor company headquarters, all laboratory testing equipment, and personnel have been moved to the new facility in Lenexa.
Project Announcements
Japan-Based TOCALO Plans Chandler, Arizona, Operations
04/17/2026
Dakota Bodies Expands Liberty, Missouri, Operations
04/17/2026
Linde Plans Garysburg, North Carolina, Air Separation Operations
04/17/2026
Netherlands-Based Signature Foods USA Plans Easley, South Carolina, Manufacturing Operations
04/16/2026
Lumber Liquidators Plans Lawrenceburg, Tennessee, Headquarters Operations
04/16/2026
Canada-Based Bioriginal Food & Science Plans Grand Junction, Colorado, Operations
04/15/2026
Most Read
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
Last Word: Don’t Lose by Winning
Q1 2026
-
Where Workforce Capacity Is Being Built — and Where It’s Being Deployed
Q1 2026
-
Advanced Manufacturing Isn’t a Buzzword—It’s a Different Location Strategy
Q1 2026